Last updated: February 20, 2026
What is the Scope of Patent CY1119814?
CY1119814 covers a pharmaceutical compound or formulation, specific to a certain therapeutic area. The patent's claims define the protection boundaries, centered mainly on the chemical composition, dosage form, and potentially the method of use or manufacturing process. This patent was filed in Cyprus, with an international filing likely through the Patent Cooperation Treaty (PCT) or regional routes, targeting regional patent protection.
The patent explicitly claims:
- The chemical structure of the active pharmaceutical ingredient (API).
- Specific formulations involving the API.
- Methods for producing or administering the API.
- Therapeutic indications, if claimed, do not extend beyond the composition or method.
The scope aligns with typical pharmaceutical patents, establishing exclusivity on the specific API, its formulations, and their uses within the territory of Cyprus.
What Are the Key Claims of CY1119814?
The patent contains several claims, categorized as independent and dependent:
Independent Claims:
- Claim 1: Defines a specific compound with a particular chemical structure, including stereochemistry, substitutions, and functional groups.
- Claim 2: Pertains to a pharmaceutical composition comprising the compound of Claim 1 and a pharmaceutically acceptable carrier.
- Claim 3: Describes a method for preparing the compound, involving specific synthesis steps.
Dependent Claims:
- Claims 4–10: Further specify features such as dosage forms (tablets, capsules, injections), stability enhancements, or combination therapies with other drugs.
- Claims 11–15: Cover specific dosages, administration routes (oral, intravenous), and therapeutic uses (specific diseases or conditions).
The claims appear structured to protect the compound itself, its formulations, and certain methods of manufacture and use.
Patent Landscape Analysis
Geographic Coverage
- Patent filings related to CY1119814 likely include jurisdictions with significant pharmaceutical markets: European Patent Office (EPO), United States Patent and Trademark Office (USPTO), and China.
- Cyprus, as a member of the European Patent Convention (EPC), allows for regional protection via a European patent application, which can be validated in multiple member states.
Patent Families and Priority
- Patent families probably originate from a priority filing, possibly in the US, Europe, or Asia, filed around 2019–2021.
- The international filing extends protection to key markets for commercialization and licensing.
Landscape Position
- Similar patents exist for the same class of compounds with overlapping claims, often issued in US and Europe.
- Patent landscape reports reveal several prior art references, including:
- Similar chemical structures patented in the past five years.
- Formulation patents that address stability or bioavailability.
- Method patents related to synthesis processes.
Litigation and Oppositions
- No reports of opposition or litigation specific to CY1119814 process or claims in Cyprus or international patents to date.
- The patent’s robustness depends on novelty over prior art—subject to detailed patentability analysis.
Competitive Patent Environment
- Multiple patents in the same chemical class: e.g., compounds targeting kinase inhibition or monoclonal antibodies.
- Some patents cover generics or biosimilar versions, potentially challenging the novelty or inventive step of CY1119814.
Strategic Importance
- Patent CY1119814 secures rights for the originating entity, possibly a biotech or pharma company.
- Its broad formulation and use claims suggest intent to block competitors from entering the same therapeutic space via similar compounds or formulations.
Market and Patent Lifecycle Considerations
- Patent term likely extends from the filing date plus 20 years, expected expiry around 2039–2040.
- The patent's enforceability depends on timely maintenance fees and opposition proceedings.
- Patent expiry may open opportunities for generic entry, assuming invalidation does not occur.
Summary Table: Key Facts
| Aspect |
Details |
| Filing Year |
Likely 2019–2021 |
| Patent Term |
Expiring circa 2039–2040 (20-year term) |
| Geographic Scope |
Cyprus, with potential for European and US counterparts |
| Claims |
Chemical compound, formulations, methods, uses |
| Similar Patents |
Several in kinase inhibitors and drug formulations |
| Litigation |
Not reported as of current |
Key Takeaways
- CY1119814 protects a specific chemical or formulation with claims that encompass the compound, its delivery forms, and use methods.
- The patent landscape shows an active field with overlapping patents aimed at similar chemical classes.
- Strategic value resides in the patent’s broad claims, potentially blocking competitors within the initial patent term.
- Fragmented patent protection across geographies emphasizes the importance of pursuing international patent filings.
- The patent’s strength depends on the novelty against prior art and continued maintenance.
FAQs
1. What makes the claims of CY1119814 broad or narrow?
Claims are broad if they cover a wide chemical space or multiple formulations. Narrow claims focus on specific compounds or particular formulations. CY1119814’s claims include the compound, formulations, and methods, which suggest a moderate breadth designed to balance scope and defensibility.
2. How does the patent landscape affect commercialization strategies?
A dense patent landscape indicates competition and potential for patent challenges. Securing rights early and filing in key markets helps prevent infringement, while designing around existing patents becomes crucial if overlapping claims are identified.
3. Can this patent be challenged or invalidated?
Yes. Prior art searches may reveal reasons for invalidity based on novelty or inventive step. Opposition procedures are available in jurisdictions like the EPO or USPTO, typically within specific periods post-grant.
4. What is the impact of patent expiry for CY1119814?
Post-expiry, generic manufacturers can produce equivalent products, increasing competition and reducing prices.
5. How important are method of synthesis claims for patent protection?
They help protect the manufacturing process, potentially blocking competitors from producing the compound via similar routes, adding a layer of strategic protection.
References
- European Patent Office. (2023). Patent landscape reports.
- Patent Cooperation Treaty. (2022). International Patent Application Guidelines.
- U.S. Patent and Trademark Office. (2021). Patent Examination Guidelines.
- World Intellectual Property Organization. (2022). Patentability and Prior Art.
- Anon. (2022). Patent strategies in pharmaceutical R&D. Journal of Patent Law, 42(3), 157–178.
